[HTML][HTML] Blood-brain barrier: from physiology to disease and back
MD Sweeney, Z Zhao, A Montagne… - Physiological …, 2018 - journals.physiology.org
The blood-brain barrier (BBB) prevents neurotoxic plasma components, blood cells, and
pathogens from entering the brain. At the same time, the BBB regulates transport of …
pathogens from entering the brain. At the same time, the BBB regulates transport of …
Recent advancements of nanomedicine in neurodegenerative disorders theranostics
S Mukherjee, VS Madamsetty… - Advanced Functional …, 2020 - Wiley Online Library
Recent times have witnessed an upsurge in the incidence of neurodegenerative disorders
such as Alzheimer's disease, Parkinson's disease, Huntington's disease, Prion disease, and …
such as Alzheimer's disease, Parkinson's disease, Huntington's disease, Prion disease, and …
Blood–brain barrier and neurodegenerative diseases—modeling with iPSC-derived brain cells
YC Wu, TM Sonninen, S Peltonen, J Koistinaho… - International journal of …, 2021 - mdpi.com
The blood–brain barrier (BBB) regulates the delivery of oxygen and important nutrients to
the brain through active and passive transport and prevents neurotoxins from entering the …
the brain through active and passive transport and prevents neurotoxins from entering the …
Advances in nanomedicines for diagnosis of central nervous system disorders
In spite of a great improvement in medical health services and an increase in lifespan, we
have witnessed a skyrocket increase in the incidence of central nervous system (CNS) …
have witnessed a skyrocket increase in the incidence of central nervous system (CNS) …
Nanotechnology for neurodegenerative disorders
The efficacy, cellular uptake and specific transport of drugs and/or imaging agents to target
organs, tissues and cells are common issues in the diagnosis and treatment of different …
organs, tissues and cells are common issues in the diagnosis and treatment of different …
RSM-CCD design of malachite green adsorption onto activated carbon with multimodal pore size distribution prepared from Amygdalus scoparia: Kinetic and isotherm …
In the present work, the activated carbon (AC) adsorbent with multimodal pore size
distribution prepared from Amygdalus scoparia as low-cost and locally available source was …
distribution prepared from Amygdalus scoparia as low-cost and locally available source was …
Blood-brain barrier dysfunction in CNS disorders and putative therapeutic targets: an overview
The blood-brain barrier (BBB) is a fundamental component of the central nervous system
(CNS). Its functional and structural integrity is vital to maintain the homeostasis of the brain …
(CNS). Its functional and structural integrity is vital to maintain the homeostasis of the brain …
[HTML][HTML] Transplantation of stem cell-derived astrocytes for the treatment of amyotrophic lateral sclerosis and spinal cord injury
Neglected for years, astrocytes are now recognized to fulfill and support many, if not all,
homeostatic functions of the healthy central nervous system (CNS). During …
homeostatic functions of the healthy central nervous system (CNS). During …
Increased surface P2X4 receptors by mutant SOD1 proteins contribute to ALS pathogenesis in SOD1-G93A mice
E Bertin, A Martinez, A Fayoux, K Carvalho… - Cellular and Molecular …, 2022 - Springer
Amyotrophic lateral sclerosis (ALS) is a fatal motoneuron (MN) disease characterized by
protein misfolding and aggregation leading to cellular degeneration. So far neither …
protein misfolding and aggregation leading to cellular degeneration. So far neither …
Breached barriers: a scoping review of blood-central nervous system barrier pathology in amyotrophic lateral sclerosis
A Mirian, A Moszczynski, S Soleimani… - Frontiers in Cellular …, 2022 - frontiersin.org
Introduction Recent studies have implicated changes in the blood-central nervous system
barriers (BCNSB) in amyotrophic lateral sclerosis (ALS). The objective of this scoping review …
barriers (BCNSB) in amyotrophic lateral sclerosis (ALS). The objective of this scoping review …